QTc Dispersion Measurement for Risk of Syncope in Patients with Aortic Stenosis

Abstract

The purposes of this study are to evaluate the clinical usefulness of maximum QTc and QTc dispersion determination in aortic stenosis, and to compare the effects of maximum QTc and QTc dispersion on the risk of syncope in aortic stenosis. The QT interval dispersion has long been known to be a marker of dispersion of ventricular repolarization and, hence, electrical instability. Additionally, it has been shown that these patients have a propensity to ventricular tachyarrhythmic syncope. The study included 86 patients with aortic stenosis who underwent left-heart catheterization and coronary angiography during investigation of syncope and 30 healthy subjects. The patients were characterized with regard to the presence or absence of a history of syncope and the severity of aortic stenosis (the degree of peak transvalvular gradient). In addition, QT max and QT dispersion measurements were corrected for heart rate according to Bazett's formula. The QTc max and QTc dispersion were greater in patients with aortic stenosis than in the healthy subjects (477 ±49 ms vs 370 ±22 ms, p < 0.001; 60 ± 13 ms vs 38 ± 1 ms, p < 0.001). Similarly, the QTc max and QTc dispersion were greater in the patients with a history of syncope than in the patients with no history of syncope (493 ±48 ms vs 459 ±4 ms, p < 0.001; 68 ±12 ms vs 53 ± 10 ms, p < 0.001). In addition, both parameters were greater in the patients with a high transvalvular gradient than in the patients with a low transvalvular gradient (489 ±49 ms vs 451 ±39 ms, p < 0.001; 65 ± 12 ms vs 50 ±9 ms, p < 0.001). Multivari ate logistic regression analysis showed that only a increased QTc dispersion had significant value for the risk of syncope in aortic stenosis. An increased QTc dispersion caused a 10.4% increase in the occurrence of syncope in aortic stenosis. These results suggest that high values of QTc dispersion are sensitive noninvasive markers to determine the risk for syncope in aortic stenosis.

Get full access to this article

View all access options for this article.

References

Bazett HC : An analysis of the time-relations of electrocardiograms. Heart J 7:353-370, 1920.

Jervell A. , Lange-Nielsen F. : Congenital deaf-mutism, functional heart disease with prolongation of the QT interval, and sudden death. Am Heart J 54:59-68, 1957.

Romano C. , Gemme G. , Pongiglione R. : Aritmie cardiache rare dell' eta' pediatrica. Clinica Pediat 45:656-683, 1963.

Schwartz PJ : Idiopathic long QT syndrome. Progress and questions. Am Heart J 109:399-411, 1985.

Ward OC : A new familial cardiac syndrome in children. J Irish Med Assoc 54:103-106, 1964.

Schwartz PJ , Wolf S. : QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 57:1074-1077, 1978 .

Day CP , McComb Jmk , Campbell Rwf : QT dispersion : An indication of arrhythmia risk in patients with long QT intervals. Br Heart J 63:342-344, 1998.

De Ambriogg L. , Negroni MS , Monza E. , et al: Dispersion of ventricular repolarization in the long QT syndrome. Am J Cardiol 68:614-620, 1991.

Kuo CS , Munakata K. , Reddy CP , et al: Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 67:1356-1367, 1983.

10.

Puddy PE , Bourassa MG : Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease. J Electrocardiol 19:203-212, 1986.

11.

Han J. , Goel BG : Electrophysiologic precursors of ventricular tachyarrhythmias. Arch Intern Med 129:749-755, 1972.

12.

Merx W. , Yoon MS , Han J. : The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation. Am Heart J 94:603-610, 1977.

13.

Abildkow JA , Vincent GM , Evans K. , et al: Distributions of body surface ECG potentials in familial QT interval prolongation (abstract). Am J Cardiol 47:480, 1981.

14.

Linker NJ , Colonna P. , Kekwick CA , et al: Assessment of QT dispersion in symptomatic patients with congenital long QT dispersion in symptomatic patients with congenital long QT syndromes . Am J Cardiol 69:634-638, 1992.

15.

Hii Jty , Wyse DG , Gillis AM , et al: Precardial QT interval dispersion as a marker of torsade de pointes: Disparate effects of class Ia antiarrhythmic drugs and amiodarone . Circulation 86:1376-1382, 1992 .